The HSPGs GPC1 and SDC1, overexpressed in a high percentage of breast cancer pathologies, enhance the mitogen effects associated with heparin-binding growth factors like Basic Fibroblast Growth Factor (FGF2), HBEGF and Hepatocyte growth factor (HGF), promoting cell proliferation [120]. This evidence concerns the gene GPC1 and breast cancer.